Last updated: February 8, 2021
Sponsor: Halodine LLC
Overall Status: Active - Not Recruiting
Phase
4
Condition
Corona Virus
Treatment
N/AClinical Study ID
NCT04517188
HDN-N02-COV24A
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Hospitalized with COVID-19
- Positive SARS-CoV-2 (rRT)-PCR within 48 hours of enrollment
Exclusion
Exclusion Criteria:
- Allergies to iodine-containing compounds
Study Design
Total Participants: 40
Study Start date:
April 01, 2021
Estimated Completion Date:
July 01, 2021